Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: Safety and efficacy

S. R. Lentz, M. Misgav, M. Ozelo, S. Z. Šalek, D. Veljkovic, M. Recht, M. Cerqueira, A. Tiede, B. Brand, M. E. Mancuso, S. Seremetis, A. Lindblom, U. Martinowitz

Research output: Contribution to journal › Article › peer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: Safety and efficacy'. Together they form a unique fingerprint.

Medicine & Life Sciences